Trials to address anemic status of children aged 36-60 months using synergistic approach in urban Vadodara
Phase 1
- Registration Number
- CTRI/2020/02/023149
- Lead Sponsor
- GC DSA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Children with mild to moderate anemia
Exclusion Criteria
1. SAM children
2. Severely anemic
3. Children with other complications
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in the Hb levels of the anemic children in experimental group.Timepoint: It will be assessed after three months of intervention in the month of february and march.
- Secondary Outcome Measures
Name Time Method 1. Increase in the compliance to existing services for children. <br/ ><br>2. To create awareness and acceptance for fortification through nutritional counselling. <br/ ><br>Timepoint: It will be assessed after three months of intervention in the month of february and march.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms are being explored in CTRI/2020/02/023149 to address childhood anemia in urban settings?
How does the synergistic approach in CTRI/2020/02/023149 compare to standard-of-care interventions for anemic children aged 36-60 months?
What biomarkers are used to assess anemia severity and treatment response in CTRI/2020/02/023149?
What adverse events have been reported in phase I trials addressing childhood anemia in urban populations?
What combination therapies or novel compounds are being evaluated alongside CTRI/2020/02/023149 for anemia in young children?